Multiplatform Metabolomics Studies of Human Cancers With NMR and Mass Spectrometry Imaging is a research paper published in Frontiers in Molecular Biosciences (2022). On theSindex it has a DataRank of 0.425. It has been cited 16 times.
Scored on demand from live citation data
Linked data & code
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.425
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →NIA NIH HHS
Grant: R01 AG070257
NCI NIH HHS
Grant: R01 CA115746
NIBIB NIH HHS
Grant: P41 EB028741
NIH HHS
Grant: S10 OD023406
NIGMS NIH HHS
Grant: T32 GM008515
NIGMS NIH HHS
Grant: T32 GM139789
National Institutes of Health
Grant: 5R01CA115746-03
Characterizing Prostate Cancer By ex vivo MRS Signatures
National Institutes of Health
Grant: 1S10OD023406-01
Upgrade of Console for 600 MHz MR Spectrometer
National Institutes of Health
Grant: 5R01AG070257-04
Metabolomic characterization of normal aging and Alzheimer's disease under anesthesia- surgery stimuli
FWCI
1.10
Citation Percentile
0.8%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals